(19)
(11) EP 4 816 562 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 25701890.3

(22) Date of filing: 21.01.2025
(51) International Patent Classification (IPC): 
C12Q 1/6886(2018.01)
G01N 33/574(2006.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6886; C12Q 2600/158; C12Q 2600/118; G01N 2333/98; G01N 2800/54; G01N 2800/56; G01N 2800/52; G01N 2500/04; G01N 33/57557
(86) International application number:
PCT/EP2025/051416
(87) International publication number:
WO 2025/162767 (07.08.2025 Gazette 2025/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.01.2024 EP 24154360

(71) Applicants:
  • Albert-Ludwigs-Universität Freiburg
    79098 Freiburg i. Br. (DE)
  • Philipps-Universität Marburg
    35037 Marburg (DE)

(72) Inventors:
  • SCHILLING, Oliver
    4052 Basel (CH)
  • COSENZA-CONTRERAS, Miguel de Jesús
    79115 Freiburg (DE)
  • WERNER, Tilman
    79106 Freiburg (DE)
  • SCHÄFER, Agnes
    57074 Siegen (DE)
  • BARTSCH, Jörg Walter
    33617 Bielefeld (DE)

(74) Representative: Krauss, Jan 
SKM-IP PartGmbB Oberanger 45
80331 München
80331 München (DE)

   


(54) ASAH1 AS A BIOMARKER FOR DETERMINING THE RISK FOR RECURRENCE OF GLIOBLASTOMA MULTIFORME IN A SUBJECT